McCutcheon FM - Search Results

1

A Coumarin-Based Array for the Discrimination of Amyloids.

Trinh N, Bhuskute KR, Varghese NR, Buchanan JA, Xu Y, McCutcheon FM, Medcalf RL, Jolliffe KA, Sunde M, New EJ, Kaur A. Trinh N, et al. Among authors: mccutcheon fm. ACS Sens. 2024 Feb 23;9(2):615-621. doi: 10.1021/acssensors.3c01334. Epub 2024 Feb 5. ACS Sens. 2024. PMID: 38315454

2

Tissue-type plasminogen activator induces conditioned receptive field plasticity in the mouse auditory cortex.

Smart C, Mitchell A, McCutcheon F, Medcalf RL, Thiele A. Smart C, et al. iScience. 2023 Jan 7;26(2):105947. doi: 10.1016/j.isci.2023.105947. eCollection 2023 Feb 17. iScience. 2023. PMID: 36711245 Free PMC article.

3

Tranexamic acid in a mouse model of cerebral amyloid angiopathy: setting the stage for a novel stroke treatment approach.

Liu Z, McCutcheon FM, Ho H, Chia J, Xiao Y, Tippett I, Keragala CB, Cloud GC, Medcalf RL. Liu Z, et al. Among authors: mccutcheon fm. Res Pract Thromb Haemost. 2023 Aug 9;7(6):102166. doi: 10.1016/j.rpth.2023.102166. eCollection 2023 Aug. Res Pract Thromb Haemost. 2023. PMID: 37694270 Free PMC article.

4

Selective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin.

Niego B, Lee N, Larsson P, De Silva TM, Au AE, McCutcheon F, Medcalf RL. Niego B, et al. PLoS One. 2017 May 16;12(5):e0177332. doi: 10.1371/journal.pone.0177332. eCollection 2017. PLoS One. 2017. PMID: 28510599 Free PMC article.

5

Plasma from patients with vaccine-induced immune thrombotic thrombocytopenia displays increased fibrinolytic potential and enhances tissue-type plasminogen activator but not urokinase-mediated plasminogen activation.

Keragala CB, McFadyen JD, Ho H, McCutcheon FM, Liu Z, Stevens H, Monagle P, Chunilal S, Medcalf RL, Tran H. Keragala CB, et al. Among authors: mccutcheon fm. J Thromb Haemost. 2024 Mar;22(3):785-793. doi: 10.1016/j.jtha.2023.10.027. Epub 2023 Nov 7. J Thromb Haemost. 2024. PMID: 37944898

6

Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis.

Draxler DF, Daglas M, Fernando A, Hanafi G, McCutcheon F, Ho H, Galle A, Gregory J, Larsson P, Keragala C, Wright DK, Tavancheh E, Au AE, Niego B, Wilson K, Plebanski M, Sashindranath M, Medcalf RL. Draxler DF, et al. J Thromb Haemost. 2019 Dec;17(12):2174-2187. doi: 10.1111/jth.14603. Epub 2019 Sep 3. J Thromb Haemost. 2019. PMID: 31393041 Free article.

7

Activated CD8⁺ T Cells Cause Long-Term Neurological Impairment after Traumatic Brain Injury in Mice.

Daglas M, Draxler DF, Ho H, McCutcheon F, Galle A, Au AE, Larsson P, Gregory J, Alderuccio F, Sashindranath M, Medcalf RL. Daglas M, et al. Cell Rep. 2019 Oct 29;29(5):1178-1191.e6. doi: 10.1016/j.celrep.2019.09.046. Cell Rep. 2019. PMID: 31665632 Free article.

8

Tranexamic acid alters the immunophenotype of phagocytes after lower limb surgery.

Draxler DF, Hanafi G, Zahra S, McCutcheon F, Ho H, Keragala CB, Liu Z, Daly D, Painter T, Wallace S, Plebanski M, Myles PS, Medcalf RL. Draxler DF, et al. Thromb J. 2022 Apr 11;20(1):17. doi: 10.1186/s12959-022-00373-3. Thromb J. 2022. PMID: 35410340 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page